Qualigen Therapeutics dismisses Baker Tilly, appoints Withum as new auditor

AIxCrypto Holdings, Inc.

Dismissed Baker Tilly US, LLP effective July 11, 2024; engaged WithumSmith+Brown, PC as successor.
Baker Tilly's reports for FY 2022 and 2023 included a going concern explanatory paragraph.
No disagreements with Baker Tilly; a material weakness was communicated to the audit committee.
Company authorized Baker Tilly to respond fully to Withum's inquiries regarding the material weakness.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.